KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Esperion Therapeutics (ESPR) Asset Utilization Ratio (2019 - 2025)

Historic Asset Utilization Ratio for Esperion Therapeutics (ESPR) over the last 7 years, with Q3 2025 value amounting to 0.85.

  • Esperion Therapeutics' Asset Utilization Ratio fell 363.31% to 0.85 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.85, marking a year-over-year decrease of 363.31%. This contributed to the annual value of 1.21 for FY2024, which is 13582.19% up from last year.
  • Per Esperion Therapeutics' latest filing, its Asset Utilization Ratio stood at 0.85 for Q3 2025, which was down 363.31% from 0.8 recorded in Q2 2025.
  • In the past 5 years, Esperion Therapeutics' Asset Utilization Ratio registered a high of 1.01 during Q4 2024, and its lowest value of 0.21 during Q2 2022.
  • Over the past 5 years, Esperion Therapeutics' median Asset Utilization Ratio value was 0.45 (recorded in 2023), while the average stood at 0.53.
  • Over the last 5 years, Esperion Therapeutics' Asset Utilization Ratio had its largest YoY gain of 294592.77% in 2021, and its largest YoY loss of 7377.49% in 2021.
  • Quarter analysis of 5 years shows Esperion Therapeutics' Asset Utilization Ratio stood at 0.26 in 2021, then grew by 4.12% to 0.27 in 2022, then soared by 102.37% to 0.54 in 2023, then soared by 85.43% to 1.01 in 2024, then decreased by 15.42% to 0.85 in 2025.
  • Its last three reported values are 0.85 in Q3 2025, 0.8 for Q2 2025, and 0.78 during Q1 2025.